ID   SIHN-005A
AC   CVCL_W318
DR   Wikidata; Q54953474
RX   PubMed=10760816;
RX   PubMed=11497283;
RX   PubMed=12124801;
CC   Doubling time: 38.0 +- 1.1 hours (PubMed=11497283).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W319 ! SIHN-005B
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
RX   PubMed=10760816; DOI=10.1002/(SICI)1097-0215(20000501)86:3<307::AID-IJC2>3.0.CO;2-I;
RA   O-Charoenrat P., Rhys-Evans P.H., Modjtahedi H., Court W., Box G.,
RA   Eccles S.A.;
RT   "Overexpression of epidermal growth factor receptor in human head and
RT   neck squamous carcinoma cell lines correlates with matrix
RT   metalloproteinase-9 expression and in vitro invasion.";
RL   Int. J. Cancer 86:307-317(2000).
//
RX   PubMed=11497283;
RA   O-Charoenrat P., Rhys-Evans P.H., Eccles S.A.;
RT   "Characterization of ten newly-derived human head and neck squamous
RT   carcinoma cell lines with special reference to c-erbB proto-oncogene
RT   expression.";
RL   Anticancer Res. 21:1953-1963(2001).
//
RX   PubMed=12124801; DOI=10.1002/ijc.10531;
RA   O-Charoenrat P., Rhys-Evans P.H., Eccles S.A.;
RT   "A synthetic matrix metalloproteinase inhibitor prevents squamous
RT   carcinoma cell proliferation by interfering with epidermal growth
RT   factor receptor autocrine loops.";
RL   Int. J. Cancer 100:527-533(2002).
//